title: Conservative treatment of femoral neuropathy following retroperitoneal hemorrhage: a case report and review of literature.
abstract: Anticoagulant drugs are used to reduce the incidence of thromboembolic events in patients at risk. However, minor and major bleeding complications may occur during anticoagulation therapy. Femoral neuropathy secondary to retroperitoneal hematoma is a well known complication of anticoagulant drugs. However, treatment of these patients is still controversial, both conservative and surgical treatments have been advocated. Herein, we report a male patient receiving warfarin for 7 years who developed femoral neuropathy due to retroperitoneal hematoma and was successfully treated with conservative methods. We suggest that conservative treatment and appropriate rehabilitation program should be given to the patients who do not demonstrate any signs of a continued bleeding and any progressive neurological deficits.
authors.affiliation: aClinics of Physical Medicine and Rehabilitation, Ankara Atatürk Education and Research Hospital bDepartment of Physical Medicine and Rehabilitation cDepartment of Cardiology, Kırıkkale University Faculty of Medicine dClinics of Radiodiagnostics, Ankara Atatürk Education and Research Hospital, Ankara, Turkey.
authors.forename: Aliye
authors.initials: A
authors.lastname: Tosun
authors.forename: Elem
authors.initials: E
authors.lastname: İnal
authors.forename: Işk
authors.initials: I
authors.lastname: Keleş
authors.forename: Murat
authors.initials: M
authors.lastname: Tulmaç
authors.forename: Özgür
authors.initials: Ö
authors.lastname: Tosun
authors.forename: Gülümser
authors.initials: G
authors.lastname: Aydın
authors.forename: Sevim
authors.initials: S
authors.lastname: Orkun
mesh_terms: D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D020428:Femoral Neuropathy / Q000209:etiology / Q000628:therapy*; D006406:Hematoma / Q000139:chemically induced / Q000150:complications*; D006801:Humans; D008297:Male; D012187:Retroperitoneal Space / Q000098:blood supply; D012307:Risk Factors; D013923:Thromboembolism / Q000188:drug therapy*; D016896:Treatment Outcome; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use; D055815:Young Adult
chemical_list: D000925:Anticoagulants; D014859:Warfarin